AP News, January 5, 2012. Consumer safety advocates are questioning the Food and Drug Administration about incomplete and seemingly erroneous data used to support the safety of silicone breast implants in an agency review last year.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Insight: Breast Implant Scandal Shows Regulators in Dark on Risk
Reuters, December 29, 2011. With the scandal surrounding France’s Poly Implant Prothese (PIP), questions arise whether there should be a national or worldwide breast implant registry.
Read More »With Doubts, FDA Panel Votes for Yaz and Related Contraceptives
National Public Radio, December 9, 2011. Doubts have been growing about Yasmin, Yaz and their sister contraceptives for several years now. And those doubts reached full flower at a Food Drug Administration advisory panel on Thursday.
Read More »Labels for Some Birth Control May Require Stronger Wording
WBALTV, December 9, 2011. Experts said the new generation of birth control pills, like Yaz and Yasmine, contain a new type of hormone called drospirenone, and several studies have suggested that women who take these types of birth control pills have twice the risk for developing blood clots compared to those taking older forms of pills.
Read More »FDA Panel Gives Tepid Okay to Birth Control Pill
Medpage Today, December 9, 2011. In a lukewarm endorsement, an FDA advisory panel voted 15-11 that the benefits of controversial drospirenone-containing oral contraceptives outweigh the risk of venous thromboembolism.
Read More »